Sunday, May 16, 2021
Home Tags Inc.

Tag: Inc.

Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic...

0
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction...

OTTAWA SAVINGS BANK ANNOUNCES FILING OF APPLICATION TO CONVERT TO AN...

0
        OTTAWA, Ill., May 14, 2021 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding...

Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™...

0
EMPAVELI, the first targeted C3 therapy, is approved for use in adults with PNH who are:Treatment naïveSwitching from C5 inhibitor Soliris® (eculizumab) Switching...

Mustang Bio Reports First Quarter 2021 Financial Results and Recent Corporate...

0
WORCESTER, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating...

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

0
PALO ALTO, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic...

Precipio Announces Q1-2021 and year-end Shareholder Update Call

0
NEW HAVEN, Conn., May 14, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2021 corporate...

Cardlytics to Present at the 16th Annual Needham Virtual Technology &...

0
ATLANTA, May 14, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced it...

FMW Media’s “New To The Street” Syndicated TV Show Features AzurRx...

0
NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- FMW Media Corp. announces that its “New To The Street” business TV show...

Qualigen Therapeutics, Inc. Reports First Quarter 2021 Financial Results and Provides...

0
Conference call scheduled for May 18, 2021 at 4:10 p.m. EDT. Revenues Increased 30 Percent to $1.9 Million...

Recro Announces Closing of Public Offering of Common Stock and Full...

0
Underwriters’ Full Exercise of Option Brings Gross Proceeds to $34.5 Million EXTON, Pa., May 14, 2021 (GLOBE NEWSWIRE) -- Recro...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News